Intracellular reduction of arginine can also be sensed by CASTOR1, which in turn may reduce mTORC1 activity, with potentially myeloma-relevant downstream effects, including increased autophagy or pro-survival effects via positive regulation of mTORC2 complex activity. This evidence concerns the gene CASTOR1 and plasma cell myeloma.